losartan has been researched along with nitroarginine in 26 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 16 (61.54) | 18.2507 |
| 2000's | 9 (34.62) | 29.6817 |
| 2010's | 1 (3.85) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carmines, PK; Inscho, EW; Navar, LG; Ohishi, K | 1 |
| Bennett, T; Compton, AM; Foulkes, R; Gardiner, SM; Hughes, B; Kemp, PA | 1 |
| Dean, RH; Ferrario, CM; Fuller, SB; Nakamoto, H; Robaczewski, DL; Winicov, E | 1 |
| Egi, Y; Matsumura, Y; Miura, A; Morimoto, S; Murata, S | 1 |
| Hajj-Ali, AF; Reilly, TM; Wong, PC | 1 |
| Hock, FJ | 1 |
| Mitchell, KD; Navar, LG; Takenaka, T | 1 |
| Majid, DS; Navar, LG; Williams, A | 1 |
| Braam, B; Koomans, HA | 1 |
| Banks, RO; Mathis, KM | 1 |
| Hempelmann, RG; Mehdorn, HM; Pradel, RH; Ziegler, A | 1 |
| Mangiapane, ML; Peters, BR | 1 |
| Braam, B; Koomans, HA; Turkstra, E | 1 |
| Boer, P; Braam, B; Gröne, HJ; Joles, JA; Koomans, HA; Verhagen, AM | 1 |
| Blair-West, JR; Harris, PJ; Rajaratne, AA; Walker, LL | 1 |
| Bessard, G; Chavanon, O; Devillier, P; Sessa, C; Stanke-Labesque, F; Tripodi, F | 1 |
| Gutierez, CI; Israel, A; Sosa, B | 1 |
| Boer, P; Braam, B; Gröne, H; Hohbach, J; Joles, JA; Koomans, HA; Verhagen, AM | 1 |
| Carrier, GO; Catravas, JD; Dimitropoulou, C; Fuchs, L; White, RE; Zhang, H | 1 |
| Doverspike, A; Hentosz, T; Huerbin, R; Nikolaidis, LA; Shannon, RP | 1 |
| Inoue, A; Ishiguro, S; Liao, JK; Miyamoto, A; Nishio, A; Wada, R | 1 |
| Glover, J; Medow, MS; Stewart, JM; Taneja, I | 1 |
| Huang, X; Longo, LD; Xiao, D; Xu, Z; Yang, S; Zhang, L | 1 |
| Clarke, D; Medow, MS; Raghunath, N; Stewart, JM; Taneja, I | 1 |
| Clarke, D; Medow, MS; Ocon, AJ; Stewart, JM; Taneja, I | 1 |
| Chang, CC; Chuang, CL; Huang, HC; Lee, FY; Lee, JY; Lee, SD; Lin, HC; Teng, TH; Wang, SS | 1 |
2 trial(s) available for losartan and nitroarginine
| Article | Year |
|---|---|
Angiotensin II type 1 receptor blockade corrects cutaneous nitric oxide deficit in postural tachycardia syndrome.
Topics: Administration, Cutaneous; Adolescent; Adult; Angiotensin II Type 1 Receptor Blockers; Blood Flow Velocity; Enzyme Inhibitors; Female; Heart Rate; Hot Temperature; Humans; Hypotension, Orthostatic; Laser-Doppler Flowmetry; Leg; Losartan; Microdialysis; Nitric Oxide; Nitric Oxide Synthase; Nitroarginine; Posture; Receptor, Angiotensin, Type 1; Research Design; Skin; Syndrome; Tachycardia; Time Factors; Treatment Outcome; Vascular Resistance; Vasodilation | 2008 |
Intradermal angiotensin II administration attenuates the local cutaneous vasodilator heating response.
Topics: Administration, Cutaneous; Adult; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Antioxidants; Ascorbic Acid; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Hot Temperature; Humans; Imidazoles; Infusions, Parenteral; Losartan; Male; Microdialysis; Nitric Oxide; Nitric Oxide Synthase; Nitroarginine; Pyridines; Receptor, Angiotensin, Type 2; Regional Blood Flow; Skin; Skin Temperature; Vasoconstrictor Agents; Vasodilation | 2008 |
24 other study(ies) available for losartan and nitroarginine
| Article | Year |
|---|---|
EDRF-angiotensin II interactions in rat juxtamedullary afferent and efferent arterioles.
Topics: Acetylcholine; Angiotensin II; Animals; Arginine; Arterioles; Biphenyl Compounds; Drug Interactions; Enalaprilat; Imidazoles; In Vitro Techniques; Kidney Medulla; Losartan; Male; Nitric Oxide; Nitroarginine; Osmolar Concentration; Rats; Renal Circulation; Tetrazoles; Vasoconstriction | 1992 |
Haemodynamic effects of human alpha-calcitonin gene-related peptide following administration of endothelin-1 or NG-nitro-L-arginine methyl ester in conscious rats.
Topics: Angiotensin II; Animals; Arginine; Biphenyl Compounds; Blood Pressure; Calcitonin Gene-Related Peptide; Captopril; Endothelins; Heart Rate; Hemodynamics; Hindlimb; Imidazoles; In Vitro Techniques; Losartan; Male; NG-Nitroarginine Methyl Ester; Nitroarginine; Rats; Regional Blood Flow; Renal Circulation; Splanchnic Circulation; Tetrazoles; Vasoconstriction | 1991 |
Angiotensin-(1-7) and nitric oxide interaction in renovascular hypertension.
Topics: Amino Acid Oxidoreductases; Angiotensin I; Angiotensin II; Angiotensins; Animals; Arginine; Biphenyl Compounds; Dogs; Hemodynamics; Hypertension, Renovascular; Imidazoles; Lisinopril; Losartan; Male; Nitric Oxide; Nitric Oxide Synthase; Nitroarginine; Peptide Fragments; Peptidyl-Dipeptidase A; Tetrazoles | 1995 |
Interaction between nitric oxide and angiotensin II on antidiuresis and norepinephrine overflow induced by stimulation of renal nerves in anesthetized dogs.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Arginine; Biphenyl Compounds; Diuresis; Dogs; Drug Interactions; Electric Stimulation; Female; Glomerular Filtration Rate; Imidazoles; Infusions, Intra-Arterial; Kidney; Kidney Function Tests; Losartan; Male; Nitric Oxide; Nitroarginine; Norepinephrine; Renal Circulation; Sodium; Synaptic Transmission; Tetrazoles | 1995 |
Modulation of renal vasoconstrictor effect of NG-nitro-L-arginine in rabbit by angiotensin II and alpha-1 adrenergic receptor blockade.
Topics: Adrenergic alpha-Antagonists; Angiotensin II; Animals; Antibodies; Arginine; Biphenyl Compounds; Drug Interactions; Hemodynamics; Hydralazine; Imidazoles; Kidney; Losartan; Male; Nitroarginine; Prazosin; Rabbits; Tetrazoles; Vasoconstrictor Agents | 1994 |
Involvement of nitric oxide-formation in the action of losartan (DuP 753): effects in an inhibitory avoidance model.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Arginine; Avoidance Learning; Biphenyl Compounds; Brain; Imidazoles; Losartan; Male; Mental Recall; Mice; Mice, Inbred Strains; Neural Inhibition; Nitric Oxide; Nitroarginine; Reaction Time; Receptors, Angiotensin; Tetrazoles | 1994 |
Contribution of angiotensin II to renal hemodynamic and excretory responses to nitric oxide synthesis inhibition in the rat.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Arginine; Biphenyl Compounds; Blood Pressure; Glomerular Filtration Rate; Imidazoles; Kidney; Losartan; Male; Natriuresis; Nitric Oxide; Nitroarginine; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; Renal Circulation; Tetrazoles | 1993 |
Inhibition of nitric oxide synthesis attenuates pressure-induced natriuretic responses in anesthetized dogs.
Topics: Animals; Arginine; Biphenyl Compounds; Blood Pressure; Dogs; Hemodynamics; Imidazoles; Losartan; Natriuresis; Nitric Oxide; Nitroarginine; Renal Circulation; Tetrazoles | 1993 |
Nitric oxide antagonizes the actions of angiotensin II to enhance tubuloglomerular feedback responsiveness.
Topics: Angiotensin II; Animals; Arginine; Biphenyl Compounds; Capillaries; Feedback; Imidazoles; Injections; Injections, Intravenous; Kidney Glomerulus; Kidney Tubules; Losartan; Male; Nitric Oxide; Nitric Oxide Synthase; Nitroarginine; Rats; Rats, Sprague-Dawley; Tetrazoles | 1995 |
Role of nitric oxide and angiotensin II in diabetes mellitus-induced glomerular hyperfiltration.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Diabetes Mellitus, Experimental; Enzyme Inhibitors; Female; Glomerular Filtration Rate; Imidazoles; Kidney; Losartan; Nephrectomy; Nitric Oxide; Nitroarginine; Rats; Rats, Sprague-Dawley; Tetrazoles | 1996 |
Contractions induced by NO synthase inhibition in isolated rat basilar artery: role of the endothelium and endogenous vasoconstrictors.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antihypertensive Agents; Arginine Vasopressin; Basilar Artery; Carbachol; Endothelins; Endothelium, Vascular; Enzyme Inhibitors; Hormone Antagonists; Indomethacin; Ketanserin; Losartan; Male; Muscarinic Agonists; Nitric Oxide Synthase; Nitroarginine; Norepinephrine; Peptides, Cyclic; Periodicity; Rats; Rats, Sprague-Dawley; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Vasoconstriction; Vasoconstrictor Agents | 1998 |
Role of nitric oxide in responses to renin-angiotensin system inhibition in sodium-depleted guinea pig and rat.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Captopril; Dipeptides; Guinea Pigs; Imidazoles; Losartan; Male; Morpholines; Nitric Oxide; Nitric Oxide Synthase; Nitroarginine; Rats; Rats, Sprague-Dawley; Renin; Renin-Angiotensin System; Sodium; Tetrazoles | 1998 |
Losartan attenuates modest but not strong renal vasoconstriction induced by nitric oxide inhibition.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Enzyme Inhibitors; Hemodynamics; Homeostasis; Kidney; Losartan; Male; Nitric Oxide Synthase; Nitroarginine; Rats; Rats, Sprague-Dawley; Renal Circulation; Vasoconstriction | 1998 |
Losartan-sensitive renal damage caused by chronic NOS inhibition does not involve increased renal angiotensin II concentrations.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Blood Pressure; Enzyme Inhibitors; Kidney; Losartan; Male; Nitric Oxide Synthase; Nitroarginine; Osmolar Concentration; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Time Factors | 1999 |
The effects of angiotensin II on blood perfusion in the rat renal papilla.
Topics: Angiotensin II; Animals; Blood Pressure; Bradykinin; Bradykinin Receptor Antagonists; Kidney Medulla; Laser-Doppler Flowmetry; Losartan; Nitroarginine; Nitroprusside; Rats; Rats, Sprague-Dawley; Receptor, Bradykinin B2; Regional Blood Flow; Renal Circulation; Ultrasonography | 1999 |
Antagonistic effects of losartan on thromboxane A2-receptors in human isolated gastroepiploic artery and saphenous vein.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Angiotensin II; Angiotensin Receptor Antagonists; Antihypertensive Agents; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Endothelin-1; Humans; In Vitro Techniques; Indomethacin; Losartan; Muscle Contraction; Muscle, Smooth, Vascular; Nitroarginine; Norepinephrine; Potassium Chloride; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Prostaglandin; Receptors, Thromboxane; Receptors, Thromboxane A2, Prostaglandin H2; Saphenous Vein; Serotonin; Stomach | 1999 |
Brain AT(2) receptor mediate vasodepressor response to footshocks: role of kinins and nitric oxide.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Blood Pressure; Bradykinin; Bradykinin Receptor Antagonists; Brain; Electroshock; Enzyme Inhibitors; Extremities; Heart Rate; Imidazoles; Injections, Intraventricular; Losartan; Male; Nitric Oxide Synthase; Nitroarginine; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptor, Bradykinin B2; Receptors, Angiotensin | 2000 |
Unchanged cardiac angiotensin II levels accompany losartan-sensitive cardiac injury due to nitric oxide synthase inhibition.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Blood Pressure; Cardiomegaly; Dose-Response Relationship, Drug; Enzyme Inhibitors; Heart; Losartan; Male; Myocardial Infarction; Myocardium; Nitric Oxide Synthase; Nitroarginine; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Vasculitis | 2000 |
Angiotensin II relaxes microvessels via the AT(2) receptor and Ca(2+)-activated K(+) (BK(Ca)) channels.
Topics: Angiotensin II; Animals; Calcium; Cells, Cultured; Dose-Response Relationship, Drug; Endothelin-1; Imidazoles; In Vitro Techniques; Losartan; Male; Membrane Potentials; Mesenteric Arteries; Muscle, Smooth, Vascular; Nitroarginine; Patch-Clamp Techniques; Peptides; Potassium Channels; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; RNA, Messenger; Tetraethylammonium; Vasodilation | 2001 |
Angiotensin-converting enzyme inhibitors improve coronary flow reserve in dilated cardiomyopathy by a bradykinin-mediated, nitric oxide-dependent mechanism.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin; Cardiomyopathy, Dilated; Coronary Circulation; Dogs; Dose-Response Relationship, Drug; Enalaprilat; Enzyme Inhibitors; Hemodynamics; Kinetics; Losartan; Nitric Oxide; Nitric Oxide Synthase; Nitroarginine; Receptor, Angiotensin, Type 1; Receptor, Bradykinin B2; Receptors, Bradykinin; Regional Blood Flow; Vasodilator Agents | 2002 |
Role of angiotensin II receptor subtypes in porcine basilar artery: functional, radioligand binding, and cell culture studies.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Angiotensin Receptor Antagonists; Animals; Basilar Artery; Cells, Cultured; Endothelial Cells; Enzyme Inhibitors; Female; Imidazoles; In Vitro Techniques; Indicators and Reagents; Losartan; Male; Muscle Contraction; Muscle, Smooth, Vascular; Nitric Oxide Synthase Type III; Nitroarginine; Pyridines; Radioligand Assay; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Swine | 2006 |
Prenatal gender-related nicotine exposure increases blood pressure response to angiotensin II in adult offspring.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Aorta; Blood Pressure; Body Weight; Calcium; Enzyme Inhibitors; Female; Imidazoles; Losartan; Mesenteric Arteries; Nicotine; Nicotinic Agonists; Nitroarginine; Pregnancy; Prenatal Exposure Delayed Effects; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Sex Characteristics; Vasoconstriction; Vasoconstrictor Agents | 2008 |
Defects in cutaneous angiotensin-converting enzyme 2 and angiotensin-(1-7) production in postural tachycardia syndrome.
Topics: Adolescent; Adult; Angiotensin I; Angiotensin-Converting Enzyme 2; Female; Humans; Losartan; Male; Nitroarginine; Peptide Fragments; Peptidyl-Dipeptidase A; Postural Orthostatic Tachycardia Syndrome; Skin; Vasodilation | 2009 |
The roles of angiotensin II receptors in the portosystemic collaterals of portal hypertensive and cirrhotic rats.
Topics: Animals; Collateral Circulation; Down-Regulation; Guanidines; Hypertension, Portal; Imidazoles; Ligation; Liver Cirrhosis; Losartan; Male; Nitric Oxide Synthase; Nitroarginine; Portal Vein; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Vasoconstriction | 2012 |